Beyond Air® Presents Positive Study Update from the At-Home LungFit® GO Pilot Study for Nontuberculous Mycobacterial Lung Disease at the American Thoracic Society International Conference 2022
May 17, 2022
Beyond Cancer, Ltd. Appoints Susan Howell Jones, CPA as Chief Financial Officer
May 17, 2022
Beyond Air® Schedules Fiscal Year 2022 Financial Results Conference Call and Webcast
May 16, 2022
Beyond Air® Reports Positive Long-Term Safety Data for High Concentration Inhaled Nitric Oxide in Bronchiolitis at the Pediatric Academic Societies Meeting 2022
April 25, 2022
Beyond Air® Presents Positive Safety and Efficacy Data for Inhaled Nitric Oxide to Treat COVID-19 at ECCMID 2022
April 25, 2022
Beyond Air® to Participate in Three Upcoming Medical Conferences
April 18, 2022
Beyond Cancer™ Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect
April 11, 2022
Beyond Cancer™ to Present Two Abstracts for Ultra-High Concentration Nitric Oxide Therapy at the 2022 AACR Annual Meeting
March 8, 2022
Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2022
February 10, 2022
Beyond Air® Announces Participation at Upcoming Investor Conferences in March 2022
February 8, 2022

Sign up for updates from Beyond Air, Inc.

Unsubscribe from all email communications. Unsubscribe